SCI论文投稿coverletter.doc

论文投稿时一般要求附带一篇“Cover Letter”，好的“Cover Letter”不仅可以使文章锦上添花，更有可能直接决定论文是否被录用。本人切身体会，以已发表论文为例，现将其写法经验归纳如下：Dear Editor,We would like to submit the enclosed manuscript entitled 论文题目, which we wish to be considered for publication in 期刊名.The work described has not been submitted elsewhere for publication, in whole or in part, and all the authors listed have approved the manuscript that is enclosed.We believe that two aspects of this manuscript will make it interesting to general readers of yourjournal. First, 论文亮点1.Second, 论文亮点2.Thank you very much for your time and consideration.Sincerely yours,作者名注意点：论文亮点一定要简洁明了，一定要有创新，突出你的文章与其它已发表论文的区别。这是 Cover Letter 的主要内容。1、 什么是cover letter?指的是SCI论文投稿信2、cover letter的内容主要包括那些?应该简述所投稿件的核心内容、主要发现和意义,拟投期刊,对稿件处理有无特殊要求等(如“not to review”list)。另外,请附上主要作者的中文姓名、通讯地址、电话、传真和e-mail地址。此外有的杂志要求推荐几位审稿人及其联系方式。以及谁已经阅读过该文(当然是牛人)。SCI论文发表投稿信写作相关知识，请咨询“辑文编译”。我投的那个杂志是要求说明你论文研究的意义,以及与这个杂志的相关性,另外还有的可能要写明你没有一搞多投等。此外临床实验要求写明符合伦理学要求。3、 如何写SCI论文cover letter?各个杂志的具体要求是不一样的,在杂志的guide for authors一般会有要求。如果没有具体的要求,大家可按照通用要求处理。SCI论文发表投稿信写作相关知识，请咨询“辑文编译”。4、SCI论文投稿信常用模板:(1)Dear Mr. *1. The work described has not been submitted elsewhere forpublication, in whole or in part, and all the authors listed have approved themanuscript that is enclosed.2. I have read and have abided by the statement of ethicalstandards for manuscripts submitted to Neuroscience.kind regards.Your sincerely,通讯作者(2)Dear Dr. 主编name:We submit our manuscript entitled 文章title to 杂志名for publication.接着简单介绍你文章的主要创新点和意义,不易过多,但要突出新意和关键点。All authors have seen the manuscript and approved to submitto your journal.Thank you very much for your attention and consideration.Sincerely yours,通讯作者(3)Dear Dr. 主编name:We submit our manuscript entitled 文章title to 杂志名for publication.接着简单介绍你文章的主要创新点和意义,不易过多,但要突出新意和关键点。All authors have seen the manuscript and approved to submitto your journal.Thank you very much for your attention and consideration.Sincerely yours,通讯作者(4)Dr. *Editor-in-Chief, *(add address) January 22, 2003Dear Dr. *,Enclosed herewith please find 3 copies of a MS by: *. *and *entitled: “*”, which we would like to submit for publicationin the *.Looking forward to your decision,With kind personal regards,Sincerely yours,*Professor of *(5)Dear Prof. *:This is a manuscript by*and *entitled “”。 It is submitted to be considered for publication as a “” in your journal. This paper is new.Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.We believe the paper may be of particular interest to the readers of your journal as it Correspondence should be addressed to *at the following address, phone and fax number, and email address:Thanks very much for your attention to our paper.Sincerely yours,CI论文投稿cover letter 投稿信模版Dear editorial board of European Journal of Cardiology,Please find enclosed the manuscript: “The angiotensin-converting enzyme is not a risk factor for myocardial infarction in French individuals”, by Sarah H., et al., to be submitted as a Short Communication to the European Journal of Neurology for consideration of publication. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication.In this manuscript, we report the results of the first study on the genetic and functional roles of the ACE on the risk of suffering a myocardial infarction in the French population. Indeed, we genotyped the rs4341 polymorphism in 531 IS cases and 549 healthy controls, and then performed functional studies by measuring serum ACE protein level and activity in healthy controls, stroke patients at baseline and stroke patients 24h after stroke symptoms onset. The results from our study did not reveal any association of the ACE variant with myocardial infarction, although it affected ACE protein level, and ischemic stroke patients showed lower ACE level than controls in the acute phase but not in the chronic phase.We believe that our findings could be of interest to the readers of European Journal of Cardiology because they bring new and strong evidence that the ACE gene and protein are not a risk factor for myocardial infarction.We hope that the editorial board will agree on the interest of this study.Sincerely yours,Sarah H. on behalf of the authors.Corresponding author: Sarah Hamilton at Cardiovascular Research Laboratory, Marie Curie Research Institute, 75000, Paris, France, xxxmariecurie.fr, phone number: +33582246xxx, fax number: +33582246xxx.Case 1Dear Editor,We would like to submit the enclosed manuscript entitled GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons, which we wish to be considered for publication in Nature Neuroscience.GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinsons disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinsons disease.Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I amSincerely yours,case2Dear Editor,We would like to submit the enclosed manuscript entitled Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release, which we wish to be considered for publication in Neuron.We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release.Sincerely yours,Case 3Sample Cover Letterthe example used is the IJEBDear Editor of the please type in journal title or acronym:Enclosed is a paper, entitled Mobile Agents for Network Management. Please accept it as a candidate for publication in the journal title. Below are our responses to your submission requirements.1. Title and the central theme of the article.Paper title: Mobile Agents for Network Management. This study reviews the concepts of mobile agents and distributed network management system. It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.2. Which subject/theme of the Journal the material fitsNew enabling technologies (if no matching subject/theme, enter Subject highly related to subject of journal but not listed by please type in journal title or acronym)3. Why the material is important in its field and why the material should be published in please type in journal title or acronym?The necessity of having an effective computer network is rapidly growing alongside the implementation of information technology. Finding an appropriate network management system has become increasingly important todays distributed environment. However, the conventional centralized architecture, which routinely requests the status information of local units by the central server, is not sufficient to manage the growing requests. Recently, a new framework that uses mobileagent technology to assist the distributed management has emerged. The mobile agent reduces network traffic, distributes management tasks, and improves operational performance. Given todays bandwidth demand over the Internet, it is important for the journal title/acronym readers to understand this technology and its benefits. This study gives a real-life example of how to use mobile agents for distributed network management. It is the first in the literature that reports the analysis of network performance based on an operational prototype of mobile agent-based distributednetwork. We strongly believe the contribution of this study warrants its publication in the journal title/acronym.4. Names, addresses, and email addresses of four expert referees.Prof. Dr. William GatesChair Professor of Information Technology321 Johnson HallPremier University Lancaster, NY 00012-6666, USAphone: +1-888-888-8888 - fax: +1-888-888-8886 e-mail:Expertise: published a related paper (TCP/IP and OSI: Four Strategies for Interconnection) in CACM, 38(3), pp. 188-198.Relationship: I met Dr. Gate only once at a conference in 1999. I didnt know him personally.Assoc Prof. Dr. John AdamsDirector of Network Research CenterCollege of Business Australian University123, H